- Home
- CCEL vs DHAI Comparison
CCEL vs DHAI Comparison
Compare CCEL & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- DHAI
- Stock Information
- Founded
- CCEL 1989
- DHAI 2007
- Country
- CCEL United States
- DHAI United States
- Employees
- CCEL N/A
- DHAI N/A
- Industry
- CCEL Managed Health Care
- DHAI
- Sector
- CCEL Health Care
- DHAI
- Exchange
- CCEL Nasdaq
- DHAI NYSE
- Market Cap
- CCEL 51.9M
- DHAI 49.1M
- IPO Year
- CCEL 1997
- DHAI N/A
- Fundamental
- Price
- CCEL $6.35
- DHAI $0.23
- Analyst Decision
- CCEL Strong Buy
- DHAI
- Analyst Count
- CCEL 1
- DHAI 0
- Target Price
- CCEL $8.50
- DHAI N/A
- AVG Volume (30 Days)
- CCEL 15.1K
- DHAI 617.6K
- Earning Date
- CCEL 04-14-2025
- DHAI 02-14-2025
- Dividend Yield
- CCEL 3.92%
- DHAI N/A
- EPS Growth
- CCEL N/A
- DHAI N/A
- EPS
- CCEL 0.05
- DHAI N/A
- Revenue
- CCEL $31,986,106.00
- DHAI $69,573,000.00
- Revenue This Year
- CCEL $2.21
- DHAI N/A
- Revenue Next Year
- CCEL $0.98
- DHAI N/A
- P/E Ratio
- CCEL $129.01
- DHAI N/A
- Revenue Growth
- CCEL 2.05
- DHAI 5.40
- 52 Week Low
- CCEL $5.75
- DHAI $0.21
- 52 Week High
- CCEL $9.50
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- CCEL 41.09
- DHAI 30.26
- Support Level
- CCEL $6.13
- DHAI $0.24
- Resistance Level
- CCEL $6.65
- DHAI $0.28
- Average True Range (ATR)
- CCEL 0.37
- DHAI 0.04
- MACD
- CCEL 0.04
- DHAI 0.01
- Stochastic Oscillator
- CCEL 42.86
- DHAI 12.53
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.